Search research articles
Contact Us
Filters
Showing results (21-30 of 88) with videos related to
Page
of 9
Sort By:
Cancer Immunology, Immunotherapy : CII
|
February 10, 2011
In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells
Shicheng Yang, Luca Gattinoni, Gattinoni Luca, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 3, 2009
Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells
Claudia Wrzesinski, Chrystal M Paulos, Andrew Kaiser, et al.
The Journal of Clinical Investigation
|
October 28, 2010
Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice
Dhanalakshmi Chinnasamy, Zhiya Yu, Marc R Theoret, et al.
The Journal of Clinical Investigation
|
August 18, 2004
Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance
Zhiya Yu, Marc R Theoret, Christopher E Touloukian, et al.
The Journal of Clinical Investigation
|
June 3, 2005
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
Luca Gattinoni, Christopher A Klebanoff, Douglas C Palmer, et al.
Plos One
|
May 16, 2014
Identification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencing
Yun Ji, Natalie Abrams, Wei Zhu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 30, 2010
Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase
Timothy L Frankel, William R Burns, Peter D Peng, et al.
JCI Insight
|
April 20, 2018
Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model
Benjamin Y Jin, Tracy E Campbell, Lindsey M Draper, et al.
Journal for Immunotherapy of Cancer
|
September 27, 2023
Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomics
Catherine M Ade, Matthew J Sporn, Sudipto Das, et al.
European Journal of Immunology
|
July 20, 2024
Identification and structural characterization of a mutant KRAS-G12V specific TCR restricted by HLA-A3
Malcolm J W Sim, Ken-Ichi Hanada, Zachary Stotz, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 88) with videos related to
Sort By:
Page
of 9
Cancer Immunology, Immunotherapy : CII
|
February 10, 2011
In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells
Shicheng Yang, Luca Gattinoni, Gattinoni Luca, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 3, 2009
Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells
Claudia Wrzesinski, Chrystal M Paulos, Andrew Kaiser, et al.
The Journal of Clinical Investigation
|
October 28, 2010
Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice
Dhanalakshmi Chinnasamy, Zhiya Yu, Marc R Theoret, et al.
The Journal of Clinical Investigation
|
August 18, 2004
Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance
Zhiya Yu, Marc R Theoret, Christopher E Touloukian, et al.
The Journal of Clinical Investigation
|
June 3, 2005
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
Luca Gattinoni, Christopher A Klebanoff, Douglas C Palmer, et al.
Plos One
|
May 16, 2014
Identification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencing
Yun Ji, Natalie Abrams, Wei Zhu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 30, 2010
Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase
Timothy L Frankel, William R Burns, Peter D Peng, et al.
JCI Insight
|
April 20, 2018
Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model
Benjamin Y Jin, Tracy E Campbell, Lindsey M Draper, et al.
Journal for Immunotherapy of Cancer
|
September 27, 2023
Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomics
Catherine M Ade, Matthew J Sporn, Sudipto Das, et al.
European Journal of Immunology
|
July 20, 2024
Identification and structural characterization of a mutant KRAS-G12V specific TCR restricted by HLA-A3
Malcolm J W Sim, Ken-Ichi Hanada, Zachary Stotz, et al.
Page
of 9